Cingulate Inc (CING) Peer Comparison

$5.40

$-0.47 (-8.01%)

As on 26-Aug-2026 16:00EDT

Market cap

$81 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

3.3

Div. Yield

0 %

Edit

	Cingulate Inc (CING)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Market cap ($ Mln)	81	16,614	17,326	13,400	12,305
Revenue ($ Mln)	--	1,054	2,782	2,436	670
Net Profit ($ Mln)	-28.80	755.85	491.50	860.62	-319.95
Net Margin (%)	--	71.69	17.67	35.33	-47.79
RoE (%)	-221.72	--	110.09	42.98	-71.14
Price to Earnings	--	19.38	36.49	17.01	--
Price-To-Book	3.30	10.05	39.43	7.27	26.44

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Cingulate Inc (CING)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Operating Revenue	0.00	1,054.37	2,782.29	2,435.92	669.50
Cost of Revenue	-0.19	103.47	1,982.07	85.67	19.14
Gross Profit	-0.54	588.53	760.62	2,236.43	829.45
Operating Expenses	24.92	841.45	216.81	1,378.74	895.93
Operating Profit (EBIT)	-24.92	109.45	583.40	971.51	-226.44
Other Income	0.00	0.00	0.00	0.00	0.00
Profit before Tax	-28.80	101.11	598.92	1,035.47	-252.08
Provision for Tax	0.00	-654.74	107.42	174.84	20.05
Profit after Tax (Net Income)	-28.80	755.85	491.50	860.62	-319.95
Minority Interest	0.00	0.00	0.00	0.00	-47.83
Consolidated Profit	0.00	0.00	0.00	0.00	0.00

Liabilities ($ Mln)

	Cingulate Inc (CING)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Shareholder's Funds	23.47	1,435.90	433.86	1,843.76	465.53
Minority Interest	0.00	0.00	0.00	0.00	-47.83
Non-Current Liabilities	968.46	384.48	187.89	288.55	1,362.63
Current Liabilities	8.63	464.70	1,435.43	361.93	283.35
Total Liabilities	15.07	1,302.02	1,975.47	2,844.42	1,385.30

Assets ($ Mln)

	Cingulate Inc (CING)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Non-Current Assets	2,858.34	895.24	1,006.90	1,243.41	440.60
Current Assets	30,207.98	1,389.84	1,050.29	1,250.82	1,671.41
Total Assets	15.07	1,302.02	1,975.47	2,844.42	1,385.30
Total Debt*	1,223.59	449.89	120.10	165.93	864.07
Net Current Assets	0.00	0.00	-385.14	888.90	1,388.07

Cashflow ($ Mln)

	Cingulate Inc (CING)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Cash From Operating Activities	-17.25	51.77	713.22	884.27	179.55
Cash Flow from Investing Activities	-0.16	-8.15	-31.14	350.44	-129.29
Cash from Financing Activities	16.15	34.89	-860.39	-969.59	74.01
Net Cash Inflow / Outflow	--	--	--	--	--

Ratios

Profitability Ratios

	Cingulate Inc (CING)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
ROCE (%)	-188.26	-30.01	53.56	32.82	-0.17
ROE (%)	-221.72	163.18	110.09	42.98	-71.14
ROA (%)	-0.09	26.53	15.64	29.32	-16.12
EBIT Margin (%)	--	5.73	21.13	31.04	-0.77
Net Margin (%)	--	71.69	17.67	35.33	-47.79
Cash Profit Margin (%)	--	0.00	0.00	0.00	0.00

Growth Ratios

	Cingulate Inc (CING)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Revenue Growth (%)	--	114.85	24.67	9.23	12.22
EBIT Growth (%)	-41.39	136.39	18.70	-3.99	93.17
Net Profit Growth (%)	-52.37	378.76	17.50	42.89	-115.58
EPS Growth (%)	8.82	353.27	26.84	50.42	-73.87
Book Value Growth (%)	41.73	816.12	164.02	-0.70	-13.57

Valuation Ratios

	Cingulate Inc (CING)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Price / Earnings	-1.05	-59.76	36.06	15.79	-2,869.63
Price / Book Value	9.40	-80.42	35.44	5.72	10.04
Dividend Yield (%)	--	--	--	--	--
EV/EBITDA	-1.10	-121.54	28.08	12.44	25.04
Market Cap ($ Cr)	--	--	--	--	--

Solvency Ratios

	Cingulate Inc (CING)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Debt to Equity	0.00	0.00	0.00	0.00	1.77
Short term debt to equity ratio	10.87	0.05	0.00	0.00	0.09
Current Ratio	3,500.01	2.99	0.73	3.46	5.90
Quick Ratio	3,500.01	2.32	0.73	3.38	5.90
Interest Coverage	0.95	1.62	--	--	-1.72

Operating Efficiency Ratios

	Cingulate Inc (CING)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Debtors to sales (%)	--	21.25	15.88	13.74	1.28
Asset Turnover	0.00	0.37	0.89	0.83	0.34
Receivable days	--	85.52	50.42	43.48	1.50
Inventory Days	-37.05	1,056.70	--	96.17	--
Payable days	1,116.21	331.01	6.26	147.97	221.81
Cash Conversion Cycle	--	811.21	--	-8.32	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly